Chemokines in allergy

Current Opinion in Immunology

Volumn 11, Issue 6, 1999, Pages 626-634

  Homey, Bernhard ^a   Zlotnik, Albert ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ALLERGIC ASTHMA; ALLERGY; ATOPIC DERMATITIS; DISEASE ASSOCIATION; GENE TARGETING; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LEUKOCYTE; NONHUMAN; PATHOLOGY; REVIEW;

EID: 0032707790     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00028-X     Document Type: Review

References (67)

1. Zlotnik A., Morales J., Hedrick J.A. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol. 19:1999;1-47. These authors provide a comprehensive overview about the discovery and biology of novel chemokines and their receptors.
2. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007.
3. •].
4. •] identified the chemokine receptors CCR5 and CXCR3 to be associated with a Th1 phenotype and CCR4 to be preferentially expressed on Th2 cells. Furthermore, expression data were confirmed by in vitro chemotaxis assays using Th1 and Th2 cells.
5. Zingoni A., Soto H., Hedrick J.A., Stoppacciaro A., Storlazzi C.T., Sinigaglia F., D'Ambrosio D., O'Garra A., Robinson D., Rocchi M.et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol. 161:1998;547-551. These authors demonstrate that CCR8 is predominantly expressed on Th2 cells and that CCR8 ligands preferentially attract this T cell subset.
6. Karpus W.J., Kennedy K.J., Kunkel S.L., Lukacs N.W. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J Exp Med. 187:1998;733-741.
7. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., Barrett T.A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol. 158:1997;4129-4136.
8. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1- deficient mice. J Exp Med. 187:1998;601-608.
9. Corrigan C.J., Kay A.B. T cells and eosinophils in the pathogenesis of asthma. Immunol Today. 13:1992;501-507.
10. Gleich G.J., Adolphson C.R., Leiferman K.M. The biology of the eosinophilic leukocyte. Annu Rev Med. 44:1993;85-101.
11. Kay A.B., Corrigan C.J. Asthma. Eosinophils and neutrophils. Br Med Bull. 48:1992;51-64.
12. Corrigan C.J., Kay A.B. Asthma. Role of T-lymphocytes and lymphokines. Br Med Bull. 48:1992;72-84.
13. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 47:1992;450-455.
14. Gratziou C., Carroll M., Montefort S., Teran L., Howarth P.H., Holgate S.T. Inflammatory T cell profile of asthmatic airways 6 hours after local allergen provocation. Am J Respir Crit Care Med. 153:1996;515-520.
15. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., Corrigan C., Durham S.R., Kay A.B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 326:1992;298-304.
16. Romagnani S., Maggi E., Parronchi P., Macchia D., Piccinni M.P., Ricci M. Increased numbers of Th2-like CD4+ T cells in target organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells. Int Arch Allergy Appl Immunol. 94:1991;133-136.
17. Walker C., Virchow J.C. Jr., Bruijnzeel P.L., Blaser K. T cells and asthma. II. Regulation of the eosinophilia of asthma by T cell cytokines. Int Arch Allergy Appl Immunol. 94:1991;248-250.
18. Zhang X., Polla B., Hauser C., Zubler R.H. T cells from atopic individuals produce IgE-inducing activity incompletely blocked by anti-interleukin-4 antibody. Eur J Immunol. 22:1992;829-833.
19. Gavett S.H., Chen X., Finkelman F., Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol. 10:1994;587-593.
20. Iwamoto I., Tomoe S., Tomioka H., Takatsu K., Yoshida S. Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J Leukoc Biol. 52:1992;572-578.
21. MacLean J.A., Ownbey R., Luster A.D. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J Exp Med. 184:1996;1461-1469.
22. Garlisi C.G., Falcone A., Kung T.T., Stelts D., Pennline K.J., Beavis A.J., Smith S.R., Egan R.W., Umland S.P. T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol. 75:1995;75-83.
23. Lukacs N.W., Strieter R.M., Chensue S.W., Kunkel S.L. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol. 10:1994;526-532.
24. Nakajima H., Iwamoto I., Tomoe S., Matsumura R., Tomioka H., Takatsu K., Yoshida S. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis. 146:1992;374-377.
25. Foster P.S., Hogan S.P., Ramsay A.J., Matthaei K.I., Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 183:1996;195-201.
26. Ying S., Robinson D.S., Meng Q., Rottman J., Kennedy R., Ringler D.J., Mackay C.R., Daugherty B.L., Springer M.S., Durham S.R.et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol. 27:1997;3507-3516.
27. Mattoli S., Stacey M.A., Sun G., Bellini A., Marini M. Eotaxin expression and eosinophilic inflammation in asthma. Biochem Biophys Res Commun. 236:1997;299-301.
28. Teran L.M., Noso N., Carroll M., Davies D.E., Holgate S., Schroder J.M. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol. 157:1996;1806-1812.
29. Lilly C.M., Nakamura H., Kesselman H., Nagler-Anderson C., Asano K., Garcia-Zepeda E.A., Rothenberg M.E., Drazen J.M., Luster A.D. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 99:1997;1767-1773.
30. Mochizuki M., Bartels J., Mallet A.I., Christophers E., Schroder J.M. IL4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol. 160:1998;60-68.
31. Teran L.M., Mochizuki M., Bartels J., Valencia E.L., Nakajima T., Hirai K., Schroder J.M. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol. 20:1999;777-786.
32. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., Canonica G.W., Jasmin C., Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest. 101:1998;2129-2139.
33. Li L., Xia Y., Nguyen A., Lai Y.H., Feng L., Mosmann T.R., Lo D. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol. 162:1999;2477-2487.
34. Gosset P., Tillie-Leblond I., Oudin S., Parmentier O., Wallaert B., Joseph M., Tonnel A.B. Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors. J Allergy Clin Immunol. 103:1999;289-297.
35. Corrigan C.J. Eotaxin and asthma: some answers, more questions. Clin Exp Immunol. 116:1999;1-3. This manuscript critically analyzes the role of eotaxin in asthma and discusses chemokines and their receptors as potential drug targets.
36. Stafford S., Li H., Forsythe P.A., Ryan M., Bravo R., Alam R. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol. 158:1997;4953-4960.
37. Elsner J., Hochstetter R., Kimmig D., Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol. 26:1996;1919-1925.
38. Jinquan T., Quan S., Feili G., Larsen C.G., Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol. 162:1999;4285-4292.
39. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 20:1999;254-257. Chemokines are redundant in their action on target cells and promiscuous in receptor usage. Moreover, certain cells concomitantly produce several chemokines with overlapping spectra of action. This manuscript develops the concept that such robustness provides a conceptual framework to understand these intriguing aspects of the chemokine system.
40. Kita H., Gleich G.J. Chemokines active on eosinophils: potential roles in allergic inflammation. J Exp Med. 183:1996;2421-2426.
41. Rothenberg M.E., MacLean J.A., Pearlman E., Luster A.D., Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med. 185:1997;785-790.
42. Gonzalo J.A., Lloyd C.M., Wen D., Albar J.P., Wells T.N., Proudfoot A., Martinez A.C., Dorf M., Bjerke T., Coyle A.J., Gutierrez-Ramos J.C. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med. 188:1998;157-167. This comprehensive study assessed the role that different chemokines (eotaxin, MCP-1, MCP-5, RANTES and MIP-1α) play in lung allergic inflammation and bronchial hyper-reactivity by blocking their activities in vivo. The results suggest that different chemokines activate different cellular and molecular pathways that in a co-ordinated fashion contribute to the complex pathophysiology of asthma and that their individual blockage results in intervention at different levels of these processes.
43. Gonzalo J.A., Pan Y., Lloyd C.M., Jia G.Q., Yu G., Dussault B., Powers C.A., Proudfoot A.E., Coyle A.J., Gearing D., Gutierrez-Ramos J.C. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol. 163:1999;403-411. Given the role of Th2 cells in lung eosinophilia and the restricted repertoire of chemokine receptors expressed by these lymphocytes, the functional role of ligands for CCR4 and CCR8 is an important question. This study shows that neutralization of MDC in a model of lung inflammation prevented airway hyper-reactivity and also caused a significant reduction in the number of eosinophils in the lung interstitium but not in the airway lumen.
44. Kay J., Gawkrodger D.J., Mortimer M.J., Jaron A.G. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 30:1994;35-39.
45. Dotterud L.K., Kvammen B., Lund E., Falk E.S. Prevalence and some clinical aspects of atopic dermatitis in the community of Sor-Varanger. Acta Derm Venereol. 75:1995;50-53.
46. Williams H.C. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol. 17:1992;385-391.
47. Schultz-Larsen F., Hanifin J.M. Secular change in the occurrence of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 176:1992;7-12.
48. Schultz-Larsen F., Diepgen T., Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol. 34:1996;760-764.
49. Bos J.D., Van Leent E.J., Sillevis Smitt J.H. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol. 7:1998;132-138.
50. Bos J.D., Hagenaars C., Das P.K., Krieg S.R., Voorn W.J., Kapsenberg M.L. Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res. 281:1989;24-30.
51. Bos J.D., van Garderen I.D., Krieg S.R., Poulter L.W. Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses. J Invest Dermatol. 87:1986;358-361.
52. Bieber T., Ring J., Braun-Falco O. Comparison of different methods for enumeration of Langerhans cells in vertical cryosections of human skin. Br J Dermatol. 118:1988;385-392.
53. Taylor R.S., Baadsgaard O., Hammerberg C., Cooper K.D. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol. 147:1991;3794-3802.
54. Wollenberg A., Kraft S., Hanau D., Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol. 106:1996;446-453.
55. Leung D.Y. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol. 96:1995;302-318.
56. Hamid Q., Naseer T., Minshall E.M., Song Y.L., Boguniewicz M., Leung D.Y. In vivo expression of IL12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol. 98:1996;225-231.
57. Grewe M., Bruijnzeel-Koomen C.A., Schopf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 19:1998;359-361. These authors propose a model of sequential Th cell activation in atopic dermatitis. During the initiation phase, atopic dermatitis is dominated by cytokines derived from activated allergen-specific Th2 cells. Subsequently, local inflammation will attract and activate infiltrating cells - such as eosinophils and macrophages - to produce IL-12, which leads to the activation of allergen-specific and non-specific Th1 and Th0 cells. Finally, IFN-γ-producing T cells may be responsible for the chronic phase of atopic dermatitis and the severity of the disease.
58. van der Heijden F.L., Wierenga E.A., Bos J.D., Kapsenberg M.L. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol. 97:1991;389-394.
59. van Reijsen F.C., Bruijnzeel-Koomen C.A., Kalthoff F.S., Maggi E., Romagnani S., Westland J.K., Mudde G.C. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol. 90:1992;184-193.
60. Grewe M., Gyufko K., Schopf E., Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet. 343:1994;25-26.
61. Hamid Q., Boguniewicz M., Leung D.Y. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest. 94:1994;870-876.
62. + T cells to lesional atopic skin.
63. Schroder J.M., Noso N., Sticherling M., Christophers E. Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J Leukoc Biol. 59:1996;1-5.
64. Ying S., Taborda-Barata L., Meng Q., Humbert M., Kay A.B. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med. 181:1995;2153-2159.
65. Picker L.J., Michie S.A., Rott L.S., Butcher E.C. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol. 136:1990;1053-1068.
66. Santamaria-Babi L.F., Picker L.J., Perez-Soler M.T., Drzimalla K., Flohr P., Blaser K., Hauser C. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med. 181:1995;1935-1940.
67. +T cells and provide a clue to explain tissue-specific homing of memory T cells to the skin.